Production (Stage)
Mustang Bio, Inc.
MBIO
$1.24
-$0.01-0.80%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -55.36% | -57.31% | -33.98% | -34.87% | -21.37% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -80.89% | -75.25% | -65.03% | -53.81% | -45.59% |
| Operating Income | 80.89% | 75.25% | 65.03% | 53.81% | 45.59% |
| Income Before Tax | 73.28% | 69.47% | 62.61% | 55.19% | 46.12% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 73.28% | 69.47% | 62.61% | 55.19% | 46.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 73.28% | 69.47% | 62.61% | 55.19% | 46.12% |
| EBIT | 80.89% | 75.25% | 65.03% | 53.81% | 45.59% |
| EBITDA | 81.29% | 75.68% | 65.20% | 53.63% | 45.37% |
| EPS Basic | 91.00% | 85.24% | 77.49% | 67.17% | 51.53% |
| Normalized Basic EPS | 94.20% | 87.83% | 79.00% | 66.25% | 49.45% |
| EPS Diluted | 91.00% | 85.24% | 77.49% | 67.17% | 51.53% |
| Normalized Diluted EPS | 94.20% | 87.83% | 79.00% | 66.25% | 49.45% |
| Average Basic Shares Outstanding | 589.67% | 251.71% | 149.00% | 61.86% | 16.69% |
| Average Diluted Shares Outstanding | 589.67% | 251.71% | 149.00% | 61.86% | 16.69% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |